John Gladish

John is Director of a Global Core Team (GCT) at Vifor Fresenius Medical Care Renal Pharma for a new therapy to treat SHPT (secondary hyperparathyroidism). Prior to joining Vifor Fresenius, he led a European consulting team that conducted competitive benchmarking, launch planning support and business development assessments. John started his career working for large Swiss pharma companies in Switzerland and the US.
He launched products, led a product lifecycle team and held positions in both marketing and marketing support functions. He received his Doctor of Pharmacy degree from the University of Illinois, complete a 2-year post-doctoral clinical fellowship at Rutgers University and management training at Harvard business school. John is a dual Swiss and US citizen and is based in Zurich, Switzerland.